Immunotherapy Focus Geneos Therapeutics specializes in personalized immunotherapies targeting neoantigens to activate the body's immune system against cancer, showcasing a unique and promising approach in the biotechnology research industry.
Novel GT-EPIC Platform The innovative GT-EPIC Platform by Geneos enables the identification, design, manufacturing, and delivery of tumor-specific neoantigen-targeted personalized immunotherapies, offering a competitive edge in the market.
Strategic Tech Stack Geneos Therapeutics leverages a diverse tech stack including W3 Total Cache, WordPress, Bootstrap, and more, indicating a commitment to utilizing technology to advance their biotech research and development processes.
Sustainable Growth Potential With a revenue range of $0-10M and $5M in funding, Geneos demonstrates solid financial health and growth potential, making them an attractive partner for collaborations and investments in the biotechnology sector.
Targeted Market Niche In a landscape dominated by larger biotech firms, Geneos stands out with a focused approach on personalized immunotherapies, providing a niche opportunity for partnerships and acquisitions within the industry.
93K
$1B
38K$1B
87K$1B
103K$1B
60K$1B
102K$1B
74K$1B
54K$1B
78K$1BGeneos Therapeutics uses 8 technology products and services including W3 Total Cache, WordPress, Google Font API, and more. Explore Geneos Therapeutics's tech stack below.
| Geneos Therapeutics Email Formats | Percentage |
| Last@geneostx.com | 38% |
| FLast@geneostx.com | 20% |
| First-Last@geneostx.com | 5% |
| Last@geneostx.com | 37% |
Biotechnology ResearchPennsylvania, United States11-50 Employees
At Geneos, our passion is to develop personalized therapies to unleash the most powerful force against cancer – your body’s own immune system. Our GT-EPIC Platform is designed to identify relevant neoantigen targets and then design, manufacture, and deliver tumor specific neoantigen-targeted personalized immunotherapies.
Company Overview
Funding & FinancialsGeneos Therapeutics has raised a total of $5M of funding over 5 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $5M.
Geneos Therapeutics's revenue is in the range of $10M
Funding & FinancialsGeneos Therapeutics has raised a total of $5M of funding over 5 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $5M.
Geneos Therapeutics's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com